Exelixis is advancing its pipeline with zanalintinib and XB010, exploring new avenues in oncology beyond its cabozantinib ...

Last week, the biotech sector was in focus, with regular pipeline and regulatory updates. Vanda Pharmaceuticals Inc. VNDA was in the spotlight after it rejected a second takeover bid by Cycle Group.

Exelixis (EXEL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Stephen Willey ...

"Exelixis and MSD to trial cancer therapies together in clinical collaboration" was originally created and published by ...

Alameda, California Tuesday, October 15, 2024, 14:00 Hrs [IST] ...

Drug makers Exelixis, Inc. (EXEL) and Merck & Co Inc.(MRK) announced Monday that they have entered into a clinical development ...

Exelixis, an Alameda, Calif., oncology company, and Rahway, N.J., drugmaker Merck said they also plan a Phase 1/2 trial and two Phase 3 studies of zanzalintinib in combination with Merck's Welireg in ...

CARACAS, Venezuela (AP) — It doesn’t feel like Christmas in Venezuela. At least not yet. Even if the president wants it to be. Residents of Caracas, the capital, woke up Tuesday to a towering ...

Epicor, a global leader of industry-specific enterprise software to promote business growth, today announced it has acquired Solenium Group Inc. and its sister company Visual SKUs Inc., both ...

Kamala Harris is depicted on NBC News accepting the Democratic presidential nomination. Screenshot: Press Gazette Most of the world’s most-visited English-language news sites grew traffic year ...

BOSTON (AP) — Three Tufts University men’s lacrosse players remained hospitalized with a rare muscle injury Monday after participating in a voluntary, supervised 45-minute workout earlier this month, ...

US Vice President Kamala Harris has been roasted over her recent word salad during a speech on Wednesday. Harris spoke at the Congressional Hispanic Caucus Institute's 47th Annual Leadership ...